Millennium Management’s SpyGlass Pharma SGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.9M Sell
418,694
-88,563
-17% -$2.18M ﹤0.01% 2209
2026
Q2
$11.3M Buy
507,257
+38,463
+8% +$834K ﹤0.01% 2166
2026
Q1
$12.1M Buy
+468,794
New +$12.6M 0.01% 1986

Other funds holding SGP

Millennium Management's SGP Position: Q3 2026 in Review

Millennium Management reduced its SpyGlass Pharma (SGP) stake by 17% in Q3 2026, selling an estimated $2.18M and leaving 418,694 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2209.

Millennium Management first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. The position peaked at $12.1M in Q1 2026. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • Millennium Management held 418,694 shares of SpyGlass Pharma worth $10.9M as of Q3 2026.
  • Millennium Management sold 88,563 SpyGlass Pharma shares in Q3 2026, an estimated $2.18M.
  • SpyGlass Pharma made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #2209 holding.
  • Millennium Management first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
  • Millennium Management's SpyGlass Pharma position peaked at $12.1M in Q1 2026.
  • 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.